Photo of Amanda Nicoll

View Scopus Profile

Amanda Nicoll

Adj Assoc Prof

 https://orcid.org/0000-0002-1855-2757
20082019
If you made any changes in Pure these will be visible here soon.

Personal profile

Biography

Amanda Nicoll is the Director of Gastroenterology at Eastern Health in Melbourne. Research interests include drug induced liver injury (hepatotoxicity), hepatocellular carcinoma, shear wave elastography, autoimmune liver disease, and haemochromatosis. She has honorary appointments with Monash University, University of Melbourne and Royal Melbourne Hospital

 

Professional Qualifications:

Medical degree (MB BS) 1987 University of Melbourne

Fellow of the RoyalAustralasianCollege of Physicians 1993

PhD 1999, University of Melbourne (Hepatitis B)

 

Clinical interests:

Managing cirrhosis and chronic hepatitis

Acute and chronic hepatitis B

Teaching the management of liver disease

Metabolic and autoimmune liver diseases

External positions

Eastern Health

Research area keywords

  • hepatology
  • liver disease
  • hepatotoxicity

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2008 2019

A prospective study of the incidence of drug-induced liver injury by the modern volatile anaesthetics sevoflurane and desflurane

Bishop, B., Hannah, N., Doyle, A., Amico, F., Hockey, B., Moore, D., Sood, S., Gorelik, A., Liew, D., Njoku, D. & Nicoll, A., Apr 2019, In : Alimentary Pharmacology and Therapeutics. 49, 7, p. 940-951 12 p.

Research output: Contribution to journal › Article › Research › peer-review

Beneficial response to mycophenolate mofetil by patients with autoimmune hepatitis who have failed standard therapy, is predicted by older age and lower immunoglobulin G and INR levels

Nicoll, A. J., Roberts, S. K., Lim, R., Mitchell, J., Weltman, M., George, J., Wigg, A., Stuart, K., Gow, P., MacQuillan, G., Tse, E., Levy, M., Sood, S., Zekry, A., Cheng, W., Mitchell, J., Skoien, R., Sievert, W., Strasser, S. I., McCaughan, G. W. & 1 others, on behalf of the ALA Clinical Research Network, Gastroenterological Society of Australia, 1 May 2019, In : Alimentary Pharmacology and Therapeutics. 49, 10, p. 1314-1322 9 p.

Research output: Contribution to journal › Article › Research › peer-review

Real-world Australian data reflect very high sustained virologic response at 12 weeks with direct acting antiviral therapy for hepatitis C and suggests highly achievable even in those without an end-of-treatment response

Williams, J., Lucarelli, N., Nicoll, A. & Lubel, J., May 2019, In : Internal Medicine Journal. 49, 5, p. 666-669 4 p.

Research output: Contribution to journal › Article › Research › peer-review

Efficacy and Safety of Mycophenolate Mofetil in Patients With Autoimmune Hepatitis and Suboptimal Outcomes After Standard Therapy

Roberts, S. K., Lim, R., Strasser, S., Nicoll, A., Gazzola, A., Mitchell, J., Siow, W., Khoo, T., Hamarneh, Z., Weltman, M., Gow, P., Janko, N., Tse, E., Mishra, G., Cheng, E. H., Levy, M., Cheng, W., Sood, S., Skoien, R., Mitchell, J. & 8 others, Zekry, A., George, J., MacQuillan, G., Wigg, A., Stuart, K., Sievert, W., McCaughan, G. & ALA Clinical Research Network, 1 Feb 2018, In : Clinical Gastroenterology and Hepatology. 16, 2, p. 268-277 10 p.

Research output: Contribution to journal › Article › Research › peer-review

Liver stiffness measurement in the primary care setting detects high rates of advanced fibrosis and predicts liver-related events in hepatitis C

Bloom, S., Kemp, W., Nicoll, A., Roberts, S. K., Gow, P., Dev, A., Bell, S., Sood, S., Kronborg, I., Knight, V., Lewis, D. & Lubel, J., 1 Sep 2018, In : Journal of Hepatology. 69, 3, p. 575-583 9 p.

Research output: Contribution to journal › Article › Research › peer-review